The global epilepsy treatment market is on track to achieve substantial growth, with projections indicating a rise to US$6.9 billion by 2031 from US$14.1 billion in 2024, representing a robust CAGR of 11% during the forecast period of 2024-2031. This significant expansion is driven by several pivotal factors reshaping the landscape of epilepsy treatment worldwide. Read More